title: Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones.
abstract: A new series of imidazolyl nitrones spin traps has been synthesized and evaluated pharmacologically. The salient structural feature of these molecules is the presence of an imidazole moiety substituted by aromatic or heteroaromatic cycles. This connectivity imparts to the nitrone superior neuroprotective properties in vivo and in parallel reduced side effects and toxicity. Thus compound 6a (a 2-phenylimidazolyl nitrone) administered intraperitoneally protects (80%) mice from lethality induced by an intracerebroventricular administration of tert-butyl hydroperoxide (t-BHP) an oxidant capable of inducing neurodegenerative processes. Administration of the archetypal nitrone phenyl-tert-butyl nitrone (PBN) at an equimolar dose also affords some protection (60%) in this test. However, this activity is accompanied by hypothermia, whereas no such effect is apparent for 6a. Moreover, previously prepared nonsubstituted or alkyl-substituted imidazolyl nitrones were shown to be extremely toxic to rats in contrast to the compounds prepared in this study. The observed activities in vivo correlate well with the calculated partition coefficients (ClogP) and HOMO energy level.
authors.affiliation: Chemistry Research Division A and Molecular Modeling Department, Institut de Recherches Servier, France.
authors.forename: A
authors.initials: A
authors.lastname: Dhainaut
authors.forename: A
authors.initials: A
authors.lastname: Tizot
authors.forename: E
authors.initials: E
authors.lastname: Raimbaud
authors.forename: B
authors.initials: B
authors.lastname: Lockhart
authors.forename: P
authors.initials: P
authors.lastname: Lestage
authors.forename: S
authors.initials: S
authors.lastname: Goldstein
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000502:physiology; D001831:Body Temperature / Q000187:drug effects; D007093:Imidazoles / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D008297:Male; D051379:Mice; D018696:Neuroprotective Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D009589:Nitrogen Oxides / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship
chemical_list: D007093:Imidazoles; D018696:Neuroprotective Agents; D009589:Nitrogen Oxides; C015388:nitrones